Cargando…
Local Immunomodulatory Strategies to Prevent Allo‐Rejection in Transplantation of Insulin‐Producing Cells
Islet transplantation has shown promise as a curative therapy for type 1 diabetes (T1D). However, the side effects of systemic immunosuppression and limited long‐term viability of engrafted islets, together with the scarcity of donor organs, highlight an urgent need for the development of new, impro...
Autores principales: | Wang, Xi, Brown, Natalie K., Wang, Bo, Shariati, Kaavian, Wang, Kai, Fuchs, Stephanie, Melero‐Martin, Juan M., Ma, Minglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425879/ https://www.ncbi.nlm.nih.gov/pubmed/34258870 http://dx.doi.org/10.1002/advs.202003708 |
Ejemplares similares
-
Engineered immunomodulatory accessory cells improve experimental allogeneic islet transplantation without immunosuppression
por: Wang, Xi, et al.
Publicado: (2022) -
An adhesive and resilient hydrogel for the sealing and treatment of gastric perforation
por: Chen, Jing, et al.
Publicado: (2021) -
Selective monitoring of insulin secretion after CRISPR interference in intact pancreatic islets despite submaximal infection
por: Shariati, Kaavian, et al.
Publicado: (2020) -
PB2441: CD34+ CELL DOSE EFFECTS ON CLINICAL OUTCOMES OF ALLO-HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT)
por: Zhou, Shengnan, et al.
Publicado: (2023) -
Unraveling the Role of Allo-Antibodies and Transplant Injury
por: Matsuda, Yoshiko, et al.
Publicado: (2016)